GS

Gail W. Sullivan

UV University of Virginia: 18 patents #13 of 1,170Top 2%
HP Hoechst Roussel Pharmaceuticals: 5 patents #48 of 109Top 45%
UF University Of Virginia Alumni Patents Foundation: 3 patents #11 of 120Top 10%
📍 Charlottesville, VA: #41 of 1,304 inventorsTop 4%
🗺 Virginia: #1,083 of 34,511 inventorsTop 4%
Overall (All Time): #197,704 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
8158604 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof Joel M. Linden, Jayson M. Rieger, Timothy L. Macdonald, Lauren J. Murphree, Robert Alan Figler 2012-04-17
7989431 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity Jayson M. Rieger, Joel M. Linden, Timothy L. Macdonald, Lauren J. Murphree, Robert Alan Figler 2011-08-02
7875595 2-polycyclic propynyl adenosine analogs having A2A agonist activity Jayson M. Rieger, Joel M. Linden, Timothy L. Macdonald, Lauren J. Murphree, Robert Alan Figler +1 more 2011-01-25
7737127 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof Joel M. Linden, Jayson M. Rieger, Timothy L. Macdonald, Lauren J. Murphree, Robert Alan Figler 2010-06-15
7605143 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity Jayson M. Rieger, Joel M. Linden, Timothy L. Macdonald, Lauren J. Murphree, Robert Alan Figler 2009-10-20
7576069 2-polycyclic propynyl adenosine analogs having A2A agonist activity Jayson M. Rieger, Joel M. Linden, Timothy L. Macdonald, Lauren J. Murphree, Robert Alan Figler +1 more 2009-08-18
7442687 2-polycyclic propynyl adenosine analogs having A2A agonist activity Jayson M. Rieger, Joel M. Linden, Timothy L. Macdonald, Lauren J. Murphree, Robert Alan Figler +1 more 2008-10-28
7427606 Method to reduce inflammatory response in transplanted tissue Joel M. Linden, Kenneth Brayman 2008-09-23
7378400 Method to reduce an inflammatory response from arthritis Jayson M. Rieger, Donald L. Kimpel, Joel M. Linden 2008-05-27
7226913 Pharmaceutical compositions having A2A adenosine receptor agonist activity Joel M. Linden, Ian Sarembock, Timothy L. Macdonald, Mark D. Okusa, Irving L. Kron +1 more 2007-06-05
7214665 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof Joel M. Linden, Jayson M. Rieger, Timothy L. Macdonald, Lauren J. Murphree, Robert Alan Figler 2007-05-08
6670334 Method and compositions for treating the inflammatory response Joel M. Linden, Jayson M. Rieger, Timothy L. Macdonald 2003-12-30
6531457 Methods and compositions for treating inflammatory response Joel M. Linden, Ian Sarembock, Timothy L. Macdonald, Mark D. Okusa, Irving L. Kron +1 more 2003-03-11
6514949 Method compositions for treating the inflammatory response Joel M. Linden, W. Michael Scheld 2003-02-04
6448235 Method for treating restenosis with A2A adenosine receptor agonists Joel M. Linden, Ian Sarembock, W. Michael Sheld 2002-09-10
6232297 Methods and compositions for treating inflammatory response Joel M. Linden, Ian Sarembock, Timothy L. Macdonald, Mark D. Okusa 2001-05-15
5877180 Method for treating inflammatory diseases with A.sub.2a adenosine receptor agonists Joel M. Linden 1999-03-02
5272153 Method of inhibiting the activity of leukocyte derived cytokines Gerald L. Mandell, William J. Novick, Jr. 1993-12-21
5196430 Method of inhibiting the activity of leukocyte derived cytokines Gerald L. Mandell, William J. Novick, Jr. 1993-03-23
5196429 Method of inhibiting the activity of leukocyte derived cytokines Gerald L. Mandell, William J. Novick, Jr. 1993-03-23
5096906 Method of inhibiting the activity of leukocyte derived cytokines Gerald L. Mandell, William J. Novick, Jr. 1992-03-17
4965271 Method of inhibiting the activity of leukocyte derived cytokines Gerald L. Mandell, William J. Novick, Jr. 1990-10-23